[HTML][HTML] The human microbiome in chronic kidney disease: a double-edged sword
Chronic kidney disease (CKD) is an increasing global health burden. Current treatments for
CKD include therapeutics to target factors that contribute to CKD progression, including …
CKD include therapeutics to target factors that contribute to CKD progression, including …
[HTML][HTML] The Human Microbiome in Chronic Kidney Disease: A Double-Edged Sword
E Wehedy, IF Shatat, S Al Khodor - Frontiers in Medicine, 2021 - ncbi.nlm.nih.gov
Chronic kidney disease (CKD) is an increasing global health burden. Current treatments for
CKD include therapeutics to target factors that contribute to CKD progression, including …
CKD include therapeutics to target factors that contribute to CKD progression, including …
[PDF][PDF] The Human Microbiome in Chronic Kidney Disease: A Double-Edged Sword
E Wehedy, IF Shatat, S Al Khodor - Front. Med. 8: 790783. doi …, 2022 - researchgate.net
Chronic kidney disease (CKD) is an increasing global health burden. Current treatments for
CKD include therapeutics to target factors that contribute to CKD progression, including …
CKD include therapeutics to target factors that contribute to CKD progression, including …
The Human Microbiome in Chronic Kidney Disease: A Double-Edged Sword
E Wehedy, IF Shatat, S Al Khodor - Frontiers in Medicine, 2022 - cir.nii.ac.jp
抄録< jats: p> Chronic kidney disease (CKD) is an increasing global health burden. Current
treatments for CKD include therapeutics to target factors that contribute to CKD progression …
treatments for CKD include therapeutics to target factors that contribute to CKD progression …
The Human Microbiome in Chronic Kidney Disease: A Double-Edged Sword
E Wehedy, IF Shatat, S Al Khodor - Frontiers in medicine, 2022 - pubmed.ncbi.nlm.nih.gov
Chronic kidney disease (CKD) is an increasing global health burden. Current treatments for
CKD include therapeutics to target factors that contribute to CKD progression, including …
CKD include therapeutics to target factors that contribute to CKD progression, including …
The Human Microbiome in Chronic Kidney Disease: A Double-Edged Sword.
E Wehedy, IF Shatat, S Al Khodor - Frontiers in Medicine, 2022 - europepmc.org
Chronic kidney disease (CKD) is an increasing global health burden. Current treatments for
CKD include therapeutics to target factors that contribute to CKD progression, including …
CKD include therapeutics to target factors that contribute to CKD progression, including …
The Human Microbiome in Chronic Kidney Disease: A Double-Edged Sword.
E Wehedy, IF Shatat, S Al Khodor - Frontiers in Medicine, 2022 - europepmc.org
Chronic kidney disease (CKD) is an increasing global health burden. Current treatments for
CKD include therapeutics to target factors that contribute to CKD progression, including …
CKD include therapeutics to target factors that contribute to CKD progression, including …